|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






Haematology 





Geriatrics 





Key Words: anaemia (iron deficiency) ferrous compounds
| The first 150 words of the full text of this article appear below. |
METHODS
Design
randomised controlled trial.
Allocation
unclear allocation concealment.*
Blinding
unblinded.*
Follow up period
60 days.
Setting
a geriatric ward in a hospital in Rehovot, Israel.
Patients
90 patients
80 years of age (mean age 85 y, 59% women) who were admitted to hospital with a diagnosis of anaemia (haemoglobin concentration 80 [5.0] to 119 g/l [7.4 mmol/l]) and ferritin concentration <40 ng/ml. Exclusion criteria were vitamin B12 deficiency, severe systemic illness, cancer, renal failure, iron therapy or blood transfusion within the previous week, coeliac disease, active known gastrointestinal blood loss, or acute infection.
Intervention
elemental iron, 15 mg (n = 30), 50 mg (n = 30), or 150 mg (n = 30) per day. Low iron doses (15 and 50 mg) were given as liquid ferrous gluconate in a simple syrup. The conventional iron dose (150 mg) was given as 1 tablet of 500 mg of ferrous calcium citrate taken
George Ioannou, MD, MS, Cara Debley, MD
VA Puget Sound Heath Care System and University of Washington, Seattle
Washington, USA
Related Article
Evid. Based Med. 2006 11: 95a.
(in Glossary)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |